Enlivex Ltd. (formerly Enlivex Therapeutics Ltd.) is an Israel-based quality longevity company operating a dual strategy: clinical development of Allocetra, a macrophage reprogramming therapy targeting osteoarthritis and inflammatory conditions, and a cryptocurrency treasury anchored in RAIN tokens—the native governance token of the RAIN decentralized prediction markets protocol built on Arbitrum. The company is preparing a Phase IIb global trial for Allocetra in knee osteoarthritis following positive Phase IIa results.
Look up ENLV using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on ENLV, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/ENLV (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.